Feature|Videos|January 2, 2025
Looking Towards the Future of CAR T-cell Trials
Delivering the same safe product to a patient while improving timelines of clinical trials
Advertisement
Episodes in this series
The panelists explain how they hope CAR T-cell clinical trials will improve over time. Tactics like developing scalable manufacturing techniques, having adaptive manufacturing, streamlining regulatory approval, and gaining early feedback from regulatory bodies will help quicken clinical trial processes.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Conflict in Middle East Disrupts Pharma Drug Supplies: Report
2
Pharmaceutical Executive Daily: Conflict in Middle East Disrupts Pharma Supply Chains
3
How Does FDA's Single Trial Decision Change The Risk Calculus for Sponsors
4
What is Shadow AI and How is it Impacting Pharma Companies?
5